Literature DB >> 7000106

Comparison of i.m. lysine acetylsalicylate and oxycodone in the treatment of pain after operation.

K Korttila, O M Pentti, J Auvinen.   

Abstract

Lysine acetylsalicylate (LAS) is a soluble salt of acetylsalicylic acid and can be given parenterally. LAS 12.5 mg kg-1 and 25 mg kg-1 were compared with oxycodone 0.15 mg kg-1 in the treatment of pain after operation in 60 patients undergoing varicose vein surgery. Both treatments almost completely relieved moderate to severe pain for the 3-h observation period. The time until the peak of action was longer after LAS (60-90 min) than after oxycodone (30-60 min). No significant differences were found between the smaller and larger doses of LAS, suggesting a plateau effect. Further clinical experiments with LAS using i.v. mode of administration and other pain models are warranted.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000106     DOI: 10.1093/bja/52.6.613

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

1.  Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt.

Authors:  L Aarons; K Hopkins; M Rowland; S Brossel; J F Thiercelin
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

2.  [The role of non-opioid analgesics in the management of postoperative pain.].

Authors:  I M Bowdler; W Seeling
Journal:  Schmerz       Date:  1993-06       Impact factor: 1.107

Review 3.  A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain.

Authors:  L S Nuutinen; J O Laitinen; T E Salomäki
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

4.  Inhibition of the cardiovascular effects of lysine acetylsalicylate by propranolol in dogs during halothane anaesthesia.

Authors:  D C Lee; M O Lee; D H Clifford
Journal:  Can Anaesth Soc J       Date:  1982-07

Review 5.  Non-steroidal anti-inflammatory drugs versus postoperative pain.

Authors:  J N Cashman
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.